Medication info
Dezartan Plus Tablet 16/12.5 mg

Dezartan Plus Tablet 16/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Light orange rectangular tablet with a score line on one side
Packaging
1 bottle/box [30 tablets/bottle]
Approval status
Active

MFDS item code 200906926 · Notified 2009.09.15 · Insurance code 643505380

Summary

Main use
Treatment of essential hypertension not controlled with individual agents
Who takes it
Adults
Adult dose
The recommended dose of this product is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this product. When clinically appropriate, a direct switch from monotherapy to this product may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment of this product is necessary in older adults. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this product (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance below 30ml/mim/1.73㎡ BSA) 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this product to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with individual agents

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who have not achieved sufficient effect with individual component therapy. It effectively lowers blood pressure, thereby reducing the burden on the blood vessels and heart. This helps to decrease the risk of complications such as heart disease or stroke. More stable and sustained effects on blood pressure control can be anticipated. It is used for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this product is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this product. When clinically appropriate, a direct switch from monotherapy to this product may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment of this product is necessary in older adults. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this product (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance below 30ml/mim/1.73㎡ BSA) 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this product to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medication may cause serious harm or even death to the fetus and newborn during pregnancy, particularly in the second and third trimesters. Therefore, it must be discontinued immediately upon confirmation of pregnancy. Patients allergic to any component of this drug or sulfonamides, those with acute or severe kidney and liver diseases, or certain blood disorders or electrolyte imbalances should not use it. Patients with reduced blood volume or sensitivity to electrolyte imbalance, patients with heart valve disease, and those with hyperkalemia should use this medication with caution, as there is also a potential increased risk of skin cancer; it is important to limit sun exposure and regularly check skin condition. This medication may cause side effects such as headache, dizziness, fatigue, and dyspepsia, and in rare cases, abnormalities in blood, kidney, liver function, or allergic reactions may occur; if any abnormal symptoms appear, consult a healthcare professional immediately. Regular monitoring of blood pressure, kidney function, electrolyte levels, etc., is important during the use of this medication. If taken with other antihypertensives or diuretics or potassium supplements, the risk of side effects may increase due to interactions, so it is essential to consult a doctor or pharmacist. Women who are pregnant or breastfeeding should not take this medication, and breastfeeding should be discontinued during the treatment. The safety of this medication has not been confirmed in children or adolescents under 18 years old; therefore, it is advisable not to use it. Elderly individuals should take caution as excessive lowering of blood pressure may burden the heart or kidneys. In case of overdose, symptoms may include lowering of blood pressure, dizziness, electrolyte imbalance, etc.; seek immediate medical attention for appropriate treatment. This medication should be kept out of reach of children and stored in its original container to maintain the quality of the drug. Caution is advised when driving or operating machinery as dizziness or fatigue may occur.

Side effects

  • headache
  • back pain
  • dizziness
  • respiratory infections
  • symptoms similar to influenza
  • sinusitis
  • bronchitis
  • urinary tract infection
  • nausea
  • contusion
Show 72 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • nasopharyngitis
  • cough
  • elevated blood sugar
  • elevated serum uric acid
  • increased ALT
  • reduced hemoglobin
  • elevated serum AST
  • increased creatinine
  • increased urea
  • elevated potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • vertigo
  • intestinal vascular edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • increased liver enzyme levels
  • abnormal liver function
  • hepatitis
  • deep vein thrombosis
  • sensory abnormalities
  • transient visual impairment
  • choroidal exudate
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • appetite suppression
  • loss of appetite
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • skin erythematous lupus-like reaction
  • activation of skin erythematous lupus
  • muscle cramps
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reaction
  • jaundice
  • sleep disturbances
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • otalgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is advisable to keep it in a cool place below 30 degrees Celsius. This is to maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Light orange rectangular tablet with a score line on one side

Package unit

1 bottle/box [30 tablets/bottle]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.